StockNews.com began coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report released on Sunday. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Global Cord Blood stock opened at $1.20 on Friday. The business has a 50 day moving average of $1.23 and a 200-day moving average of $1.36. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The company has a market capitalization of $145.86 million, a P/E ratio of 1.88 and a beta of 0.16.
Global Cord Blood Company Profile
Recommended Stories
- Five stocks we like better than Global Cord Blood
- How to Capture the Benefits of Dividend Increases
- Chipotle Mexican Grill Stock Split: Where Does it Go From Here?
- 3 Warren Buffett Stocks to Buy Now
- Arm Holdings and Micron: Top 2 AI Stocks to Buy and Hold
- How to Choose Top Rated Stocks
- Best Buy Stock May Be Best Bought Before the Holiday Season
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.